Scarica l'app Stockscreener
52.68
1.62%
-0.87
Dopo l'orario di chiusura:
52.64
-0.04
-0.08%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$53.55
Aprire:
$54.19
Volume 24 ore:
14.80M
Relative Volume:
0.92
Capitalizzazione di mercato:
$78.30B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
22.09
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
-2.32%
1M Prestazione:
-18.46%
6M Prestazione:
-48.70%
1 anno Prestazione:
-49.76%
Intervallo 1D:
$52.52
$54.40
Intervallo di 1 settimana:
$52.52
$54.48
Portata 52W:
$52.52
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
52.68 | 79.59B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
84.47 | 147.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
306.76 | 117.12B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
76.15 | 98.82B | 35.48B | 4.64B | 5.41B | 3.582 |
EW
Edwards Lifesciences Corp
|
81.38 | 46.84B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific plunges 43% YTD amid weak outlook but shows potential for recovery with new Buy rating. - Pluang
Boston Scientific Corp. stock (US10117L1017): recent earnings, device pipeline and outlook - AD HOC NEWS
Why this $23-billion money manager is buying Caterpillar and selling Boston Scientific - The Globe and Mail
Boston Scientific Corp Investor Event at the Scientific Session of the American College of Cardiology Transcript - GuruFocus
Here's How Boston Scientific Is Expanding Its Global Growth - Yahoo Finance
Jim Cramer on Boston Scientific: “I Think You Gotta Hold It” - Insider Monkey
Boston Scientific (BSX) Fell Amid Concerns Over Growth Durability - Yahoo Finance
Trek Financial LLC Sells 38,145 Shares of Boston Scientific Corporation $BSX - MarketBeat
NWK Group, Inc.'s Boston Scientific Corp(BSX) Holding History - GuruFocus
Strategic Advisers Fidelity Alternatives Fund's Boston Scientific Corp(BSX) Holding History - GuruFocus
Is Boston Scientific (BSX) Quietly Recasting Its Ownership Structure To Sharpen Its Investment Story? - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Boston Scientific (BSX) Valuation After Morningstar Downgrade And Significantly Undervalued Rating - Yahoo Finance
Boston Scientific Corp. stock (US10117L1017): Hits 52-week low at $53.10 - AD HOC NEWS
Boston Scientific stock hits 52-week low at $53.10 By Investing.com - Investing.com Nigeria
Boston Scientific stock hits 52-week low at $53.10 - Investing.com
Boston Scientific Corp. stock (US10117L1017): FMR LLC cuts major stake in Q1 2026 - AD HOC NEWS
Boston Scientific Insiders Sold US$1.2m Of Shares Suggesting Hesitancy - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Jim Cramer Warns This Market Is Far More Brutal Than Dot-Com Bubble Era: 'The Difference Between Now And 1999 Is...' - Benzinga
Boston Scientific faces share pressure but holds strong in key medtech areas with growth potential. - Pluang
Boston Scientific Corp. stock outperforms competitors despite losses on the day - MarketWatch
Boston Scientific (NYSE: BSX) director Ellen M. Zane receives $215,000 stock grant - Stock Titan
Boston Scientific (NYSE: BSX) director receives 3,800-share restricted stock grant - Stock Titan
Boston Scientific (NYSE: BSX) director receives major equity awards - Stock Titan
Boston Scientific (NYSE: BSX) director receives deferred stock unit awards as equity pay - Stock Titan
Boston Scientific (NYSE: BSX) director granted deferred stock units - Stock Titan
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific (BSX) director receives $215,000 restricted stock award - Stock Titan
BSX Stock Quote Price and Forecast - CNN
9 New 5-Star Stocks This Week - Morningstar
Boston Scientific Corp. stock (US10117L1017): Shares open at $53.89 amid acquisition scrutiny - AD HOC NEWS
Boston Scientific Corp. stock (US10117L1017): Shares slide amid valuation debate - AD HOC NEWS
Boston Scientific Corp. stock (US10117L1017): Shares hit 52-week low after earnings beat and guidanc - AD HOC NEWS
Boston Scientific Corp (BSX) Stock Down 4.7% -- Now Undervalued? GF Score: 84/100 - GuruFocus
Endeavor plans to redevelop 24-acre Boston Scientific campus in Minnetonka - The Business Journals
Boston Scientific’s pacemaker recall is most serious type: FDA - Modern Healthcare News
Fund Update: 191,081 BOSTON SCIENTIFIC (BSX) shares added to Glenview Trust Co portfolio - Quiver Quantitative
Boston Scientific principal’s advice: ‘Build the doors you want to walk through’ - The Business Journals
Boston Scientific Corp. Stock (US10117L1017): Hits 52-Week Low Amid Analyst Downgrades and Guidance - AD HOC NEWS
Boston Scientific Announces Software Upgrade for Pacemakers Amid Recall - GuruFocus
US FDA issues recall of Boston Scientific heart devices - Reuters
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Penumbra shareholders approve merger with Boston Scientific - Investing.com
Fund Update: 543,460 BOSTON SCIENTIFIC (BSX) shares added to Mawer Investment Management Ltd. portfolio - Quiver Quantitative
FMR LLC updates Boston Scientific holding (NYSE: BSX) — 75.8M shares - Stock Titan
Do Boston Scientific's (NYSE:BSX) Earnings Warrant Your Attention? - Yahoo Finance
Boston Scientific Corporation Restated Certificate of Incorporation: Key Provisions, Director Rights, and Shareholder Protections - Minichart
Boston Scientific shareholders approve charter amendments and board elections By Investing.com - Investing.com Canada
Boston Scientific shareholders approve charter amendments and board elections - Investing.com
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.07%
0.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):